Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Advisory Resource Group

Advisory Resource Group reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 37.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,699 shares of the biotechnology company’s stock after selling 1,004 shares during the quarter. Advisory Resource Group’s holdings in Axon Enterprise were worth $1,010,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Public Sector Pension Investment Board lifted its holdings in shares of Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc lifted its stake in Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $221,000. Sequoia Financial Advisors LLC grew its position in shares of Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after acquiring an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $814,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on AXON shares. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Robert W. Baird lifted their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Northland Securities lifted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Finally, The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $542.15.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock valued at $30,721,337 over the last quarter. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $679.24 on Friday. Axon Enterprise, Inc. has a twelve month low of $255.68 and a twelve month high of $698.67. The business’s 50-day moving average price is $623.43 and its 200 day moving average price is $495.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $51.79 billion, a PE ratio of 175.51, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.